In addition to increasing bone mass and reducing blood glucose levels, this study revealed that activating the HIF-1α pathway by specifically knocking out Vhl in osteoblasts partially alleviated the symptoms of streptozotocin (STZ)-induced type 1 diabetes mellitus (T1DM). Here, HIF1A is linked to type 1 diabetes mellitus.